A major limitation of the existing clinical literature is the lack of consistent adjustment for key confounding variables such as age, BMI, smoking, alcohol intake, and comorbid conditions such as diabetes and metabolic syndrome, which are all known to influence circulating testosterone and AR activity [55,56]. This evidence concerns the gene AR and metabolic syndrome.